Acadia Pharmaceuticals buy Deutsche Bank Aktiengesellschaft
Start price
21.05.25
/
50%
€19.69
Target price
21.05.26
€30.98
Performance (%)
-3.35%
Price
27.04.26
€19.03
Summary
This prediction is currently active. With a performance of -3.35%, the BUY prediction by Deutsche_Bank_Aktien is trending in the wrong direction. This prediction currently runs until 21.05.26. The prediction end date can be changed by Deutsche_Bank_Aktien at any time. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 1.467% | 1.467% |
| iShares Core DAX® | -1.424% | 8.918% |
| iShares Nasdaq 100 | 3.274% | 16.275% |
| iShares Nikkei 225® | 1.745% | 16.239% |
| iShares S&P 500 | 1.447% | 10.913% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft to $35.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat